2. What has led to the increase in MRSA transmission in the community? What are some of the challenges in addressing this problem in the community? How is it often identified and how can it be passed in communities?
3.Discuss why there is no “typical” STI patient. Why does the presence of an STI greatly increase the risk of HIV transmission?
4.Based on what you saw in the YouTube presentation, do you think that PrEP/Truvada it is effective in preventing HIV/AIDS.